Johnson & Johnson (NYSE:JNJ) announced today that it has entered into an agreement with the African Vaccine Acquisition Trust (AVAT)  to make 220 million COVID-19 vaccine doses available to the 55 African Union member countries. AVAT also has the potential to order an additional 180 million doses to bring the total to 440 million through…